首页 正文

Sotatercept in Patients with Pulmonary Arterial Hypertension at High Risk for Death

{{output}}
Background: Sotatercept improves exercise capacity and delays the time to clinical worsening in patients with World Health Organization (WHO) functional class II or III pulmonary arterial hypertension. The effects of add-on sotat... ...